Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegrable microspheres

Journal of Pharmaceutical Sciences

Volumn 88, Issue 2, 1999, Pages 161-165

  Yang, Tzung Horng ^a   Dong, Aichun ^b   Meyer, Jeff ^a   Johnson, Olufunmi L ^c   Cleland, Jeffrey L ^d   Carpenter, John F ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF NORTHERN COLORADO   (United States)

^c ALKERMES INC   (United States)

^d GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXCIPIENT; HUMAN GROWTH HORMONE; MICROSPHERE; POLYGLACTIN; ZINC ION;

ALPHA HELIX; ARTICLE; ENCAPSULATION; INFRARED SPECTROSCOPY; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE;

EID: 0033047392     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980423n     Document Type: Article

References (11)

1. Putney, S. D.; Burke, P. A. Improving protein therapeutics with sustained-release formulations. Nature Biotech. 1998, 16, 153-157.
2. Dong, A.; Prestrelski, S. J.; Allison, S. D.; Carpenter, J. F. Infrared spectroscopic studies of lyophilization- and temperature-induced protein aggregation. J. Pharm. Sci. 1995, 84, 415-424.
3. Carpenter, J. F.; Chang, B. S. Lyophilization of protein pharmaceuticals. In Biotechnology and Biopharmaceutical Manufacturing, Processing and Preservation; Avis, K. E.; Wu, V. L., Eds., Interpharm: Buffalo Grove, IL, 1996; pp 199-264.
4. Prestrelski, S. J.; Tedeschi, N.; Arakawa, T.; Carpenter, J. F. Dehydration-induced conformational changes in proteins and their inhibition by stabilizers. Biophys. J. 1993, 65, 661-671.
5. Allison, S.D.; Dong, A.; Carpenter, J. F. Counteracting effects of thiocyanate and sucrose on chymotrypsinogen secondary structure and aggregation during freezing, drying and rehydration. Biophys. J. 1996, 71, 2022-2032
6. Cleland, J. L.; Jones, A. J. S. Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres. Pharm. Res. 1996, 13, 1464-1475.
7. Johnson, O. L.; Cleland, J. L.; Lee, H. J.; Charnis, M.; Duenas, E.; Jaworowicz, W.; Shepard, D.; Shahzamani, A.; Jones, A. J. S.; Putney, S. D. A month-long effect from a single injection of microencapsulated human growth hormone. Nature Med. 1996, 2, 795-799.
8. Cleland, J. L.; Mac, A.; Boyd, B.; Yang, J.; Duenas, E. T.; Yeung, D.; Brooks, D.; Hsu, C.; Chu, H.; Mukku, V.; Jones, A. J. S. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res. 1997, 14, 420-425.
9. Yang, J.; Cleland, J. L. Factors affecting the in vitro release of recombinant human interferon-g (rhIFN-r) from PLGA Microsphres. J. Pharm. Sci. 1997, 86, 908-914.
10. Dong, A.; Caughey, W. S. Infrared methods for study of hemoglobin reactions and structures. Methods. Enzymol. 1994, 232, 139-175.
11. Kendrick, B. S.; Dong, A.; Allison, S. D.; Manning, M. C.; Carpenter, J. F. Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states. J. Pharm. Res. 1996, 85, 155-158.